These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10517045)

  • 1. Histological findings after long-term infusion of intrathecal ketamine for chronic pain: a case report.
    Stotz M; Oehen HP; Gerber H
    J Pain Symptom Manage; 1999 Sep; 18(3):223-8. PubMed ID: 10517045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of neuropathic cancer pain with continuous intrathecal administration of S +-ketamine.
    Vranken JH; van der Vegt MH; Kal JE; Kruis MR
    Acta Anaesthesiol Scand; 2004 Feb; 48(2):249-52. PubMed ID: 14995949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ketamine infusion therapy for refractory neuralgia in spinal disease: report of two cases].
    Matsuda W; Matsumura A; Enomoto T; Nose T; Suga A; Miyabe M; Toyooka H
    No Shinkei Geka; 1999 Feb; 27(2):195-200. PubMed ID: 10065454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain.
    Yang CY; Wong CS; Chang JY; Ho ST
    Can J Anaesth; 1996 Apr; 43(4):379-83. PubMed ID: 8697554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the use of ketamine in pain management.
    Tawfic QA
    J Opioid Manag; 2013; 9(5):379-88. PubMed ID: 24353050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.
    Persson J; Hasselström J; Wiklund B; Heller A; Svensson JO; Gustafsson LL
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):750-8. PubMed ID: 9698948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia.
    Lin TC; Wong CS; Chen FC; Lin SY; Ho ST
    Can J Anaesth; 1998 Feb; 45(2):175-7. PubMed ID: 9512855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of subarachnoid administration of preservative-free S(+)-ketamine on spinal cord and meninges in dogs.
    Rojas AC; Alves JG; Moreira E Lima R; Esther Alencar Marques M; Moreira de Barros GA; Fukushima FB; Modolo NS; Ganem EM
    Anesth Analg; 2012 Feb; 114(2):450-5. PubMed ID: 22167772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain.
    Vranken JH; Troost D; Wegener JT; Kruis MR; van der Vegt MH
    Pain; 2005 Sep; 117(1-2):231-5. PubMed ID: 16098665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance.
    Sator-Katzenschlager S; Deusch E; Maier P; Spacek A; Kress HG
    Anesth Analg; 2001 Oct; 93(4):1032-4, table of contents. PubMed ID: 11574378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial.
    Amr YM
    Pain Physician; 2010; 13(3):245-9. PubMed ID: 20495588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrathecal injection of ketamine and clonidine for chronic neuropathic pain model in rats].
    He ZH; Guo QL; Zou WY; Huang CS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):702-5. PubMed ID: 17767070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ketamine in the treatment of mucositis pain.
    Slatkin NE; Rhiner M
    Pain Med; 2003 Sep; 4(3):298-303. PubMed ID: 12974832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man.
    Warncke T; Stubhaug A; Jørum E
    Pain; 2000 Jun; 86(3):293-303. PubMed ID: 10812259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine: an introduction for the pain and palliative medicine physician.
    Okon T
    Pain Physician; 2007 May; 10(3):493-500. PubMed ID: 17525784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.
    Neri CM; Pestieau SR; Darbari DS
    Paediatr Anaesth; 2013 Aug; 23(8):684-9. PubMed ID: 23565738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain.
    Mercadante S; Lodi F; Sapio M; Calligara M; Serretta R
    J Pain Symptom Manage; 1995 Oct; 10(7):564-8. PubMed ID: 8537699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose subcutaneous ketamine infusion and morphine tolerance.
    Bell RF
    Pain; 1999 Oct; 83(1):101-3. PubMed ID: 10506678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients.
    Wagemans MF; van der Valk P; Spoelder EM; Zuurmond WW; de Lange JJ
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):1033-8. PubMed ID: 9311403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.